Comments on the 2025 Advance Notice
The Medicare Rights Center welcomes CMS’s efforts to refine Medicare Advantage payment methodology and supports further action to improve costs and the beneficiary experience, program wide.
Comments Supporting the Complete Rescission of the 2018 Association Health Plan Final Rule
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Proposed Rescission of the 2018 Association Health Plan Final Rule. We applaud this full rescission of the final 2018 Association Health Plan (AHP) rule. Though the rule was never fully implemented, this rescission will eliminate any uncertainty regarding applicable definitions and standards.
Comments on Proposed Changes to Medicare Advantage and Part D for 2025
The Medicare Rights Center commented on the Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule.
Comments on 2024 Physician Fee Schedule
Medicare Rights comments on medically necessary dental and mental health and substance use disorder provisions in the 2024 Physician Fee Schedule.
Comments on the Short-Term, Limited-Duration Insurance Proposed Rule
Medicare Rights comments in support of provisions in the Short-Term, Limited-Duration Insurance proposed rule.
Comments on Health and Human Services Grants Regulation
Medicare Rights comments in support of the Health and Human Services Grants Regulation proposed rule.
Separate Licensing Standards for Relative or Kinship Foster Family Homes
These comments from the Medicare Rights Center are in support of separate licensing standards for relative or kinship foster family homes.
Omitting Food From In-Kind Support and Maintenance Calculations
Medicare Rights comments in support of removing food from the calculation of in-kind benefits for Supplemental Security Income (SSI).
The Medicare Drug Price Negotiation Program
Callers to our national helpline regularly report struggling to afford the prescription medications they need to maintain their health and well-being. The Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program could offer much-needed relief. In our comments, we offer recommendations to implement this program in a way that enhances affordability, ensures accuracy, and maximizes transparency.
Interoperability and Prior Authorization Proposed Rule
The Medicare Rights Center (Medicare Rights) appreciates this opportunity to comment on the Advancing Interoperability and Improving Prior Authorization Processes proposed rule.
Prior authorization is creating an ever-increasing burden on patients. We support many of the Centers for Medicare & Medicaid Services (CMS) provisions in this proposed rule that would reduce this burden by improving processes, timelines, access to information, and communication.